Literature DB >> 15479315

Comparison of surgical site and patient's history with a simplified risk score for the prediction of postoperative nausea and vomiting.

C C Apfel1, P Kranke, L H J Eberhart.   

Abstract

Although site of surgery and previous occurrence of postoperative nausea and vomiting are often used to decide whether prophylactic anti-emetic drugs are indicated, the value of these predictors is unclear. We compared these two risk factors against a simplified four-factor risk score. We analysed data from 1566 adult inpatients who received balanced anaesthesia without prophylactic anti-emetics. Sensitivity, specificity, predictive value and area under the receiver operating characteristic curve were used to quantify predictive properties. Nausea and vomiting occurred in 600 (38.3%) patients within 24 h. Sensitivity and specificity were, respectively, 47% and 59% for surgical site; 47% and 70% for history of postoperative nausea and vomiting; and 58% and 70% for risk score with three or more factors. The area under the curve for surgical site was 0.53 (95% CI 0.50-0.56); that for patient's history was 0.58 (95% CI 0.56-0.61) while for risk score it was 0.68 (95% CI 0.66-0.71; P < 0.001). Prediction using surgical site or patient's history alone was poor while the simplified risk score provided clinically useful sensitivity and specificity.

Entities:  

Mesh:

Year:  2004        PMID: 15479315     DOI: 10.1111/j.1365-2044.2004.03875.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  29 in total

1.  Fast track colorectal surgery.

Authors:  Timothy C Counihan; Joanne Favuzza
Journal:  Clin Colon Rectal Surg       Date:  2009-02

Review 2.  Nausea, vomiting, and hiccups: a review of mechanisms and treatment.

Authors:  Daniel E Becker
Journal:  Anesth Prog       Date:  2010

Review 3.  Nausea and vomiting after surgery under general anesthesia: an evidence-based review concerning risk assessment, prevention, and treatment.

Authors:  Dirk Rüsch; Leopold H J Eberhart; Jan Wallenborn; Peter Kranke
Journal:  Dtsch Arztebl Int       Date:  2010-10-22       Impact factor: 5.594

Review 4.  Dexamethasone for prevention of postoperative nausea and vomiting in patients undergoing thyroidectomy: meta-analysis of randomized controlled trials.

Authors:  Chia-Che Chen; Fahad Javaid Siddiqui; Ta-Liang Chen; Edwin Shih-Yen Chan; Ka-Wai Tam
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

Review 5.  An update on the management of postoperative nausea and vomiting.

Authors:  Xuezhao Cao; Paul F White; Hong Ma
Journal:  J Anesth       Date:  2017-04-28       Impact factor: 2.078

6.  Impact of drains on nausea and vomiting after thyroid and parathyroid surgery: a randomized controlled trial.

Authors:  B M Künzli; M Walensi; J Wilimsky; C Bucher; T Bührer; C Kull; A Zuse; C A Maurer
Journal:  Langenbecks Arch Surg       Date:  2019-06-26       Impact factor: 3.445

7.  Association between serotonin transport polymorphisms and postdischarge nausea and vomiting in women following breast cancer surgery.

Authors:  Susan W Wesmiller; Catherine M Bender; Susan M Sereika; Gretchen Ahrendt; Marguerite Bonaventura; Dana H Bovbjerg; Yvette Conley
Journal:  Oncol Nurs Forum       Date:  2014-03-01       Impact factor: 2.172

Review 8.  Mechanisms underlying postoperative nausea and vomiting and neurotransmitter receptor antagonist-based pharmacotherapy.

Authors:  Tong J Gan
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 9.  [Nausea and vomiting in the postoperative phase. Expert- and evidence-based recommendations for prophylaxis and therapy].

Authors:  C C Apfel; P Kranke; S Piper; D Rüsch; H Kerger; M Steinfath; K Stöcklein; D R Spahn; T Möllhoff; K Danner; A Biedler; M Hohenhaus; B Zwissler; O Danzeisen; H Gerber; F-J Kretz
Journal:  Anaesthesist       Date:  2007-11       Impact factor: 1.041

10.  P6 acupoint stimulation for prevention of postoperative nausea and vomiting in patients undergoing craniotomy: study protocol for a randomized controlled trial.

Authors:  Jian-qin Lv; Rui-zhi Feng; Ning Li
Journal:  Trials       Date:  2013-05-28       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.